Leukemia, Myeloid, Acute

"Leukemia, Myeloid, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Descriptor ID	D015470
MeSH Number(s)	C04.557.337.539.275
Concept/Terms	Leukemia, Myeloid, Acute Leukemia, Myeloid, Acute Acute Myeloid Leukemia Acute Myeloid Leukemias Leukemias, Acute Myeloid Myeloid Leukemias, Acute ANLL Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Myeloblastic, Acute Leukemia, Myelocytic, Acute Leukemia, Myelogenous, Acute Leukemia, Nonlymphoblastic, Acute Leukemia, Nonlymphocytic, Acute Myeloblastic Leukemia, Acute Acute Myeloblastic Leukemia Acute Myeloblastic Leukemias Leukemia, Acute Myeloblastic Leukemias, Acute Myeloblastic Myeloblastic Leukemias, Acute Myelocytic Leukemia, Acute Acute Myelocytic Leukemia Acute Myelocytic Leukemias Leukemia, Acute Myelocytic Leukemias, Acute Myelocytic Myelocytic Leukemias, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Nonlymphoblastic Leukemia, Acute Acute Nonlymphoblastic Leukemia Acute Nonlymphoblastic Leukemias Leukemia, Acute Nonlymphoblastic Leukemias, Acute Nonlymphoblastic Nonlymphoblastic Leukemias, Acute Nonlymphocytic Leukemia, Acute Acute Nonlymphocytic Leukemia Acute Nonlymphocytic Leukemias Leukemia, Acute Nonlymphocytic Leukemias, Acute Nonlymphocytic Nonlymphocytic Leukemias, Acute Acute Myelogenous Leukemia Acute Myelogenous Leukemias Leukemias, Acute Myelogenous Myelogenous Leukemias, Acute Myeloid Leukemia, Acute, M1 Myeloid Leukemia, Acute, M1 Leukemia, Myeloid, Acute, M1 Acute Myeloid Leukemia without Maturation Leukemia, Myeloid, Acute, M2 Leukemia, Myeloid, Acute, M2 Myeloid Leukemia, Acute, M2 Acute Myeloid Leukemia with Maturation

Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid, Acute".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Leukemia [C04.557.337]
Leukemia, Myeloid [C04.557.337.539]
Leukemia, Myeloid, Acute [C04.557.337.539.275]

Below are MeSH descriptors whose meaning is related to "Leukemia, Myeloid, Acute".

Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid, Acute".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Leukemia, Myeloid, Acute" by people in this website by year, and whether "Leukemia, Myeloid, Acute" was a major or minor topic of these publications.

Bar chart showing 98 publications over 23 distinct years, with a maximum of 8 publications in 2011 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	2	0	2
2001	0	1	1
2002	1	0	1
2004	2	0	2
2005	1	0	1
2007	3	0	3
2008	5	2	7
2009	2	1	3
2010	5	1	6
2011	8	0	8
2012	5	1	6
2013	5	1	6
2014	7	0	7
2015	6	0	6
2016	4	2	6
2017	6	0	6
2018	5	0	5
2019	2	0	2
2020	2	0	2
2021	6	0	6
2022	8	0	8
2023	1	0	1
2024	3	0	3

Below are the most recent publications written about "Leukemia, Myeloid, Acute" by people in Profiles.

Hlavaty SI, Salcido KN, Pniewski KA, Mukha D, Ma W, Kannan T, Cassel J, Srikanth YVV, Liu Q, Kossenkov A, Salvino JM, Chen Q, Schug ZT. ACSS1-dependent acetate utilization rewires mitochondrial metabolism to support AML and melanoma tumor growth and metastasis. Cell Rep. 2024 Dec 24; 43(12):114988.

View in: PubMed
Wysota M, Konopleva M, Mitchell S. Novel Therapeutic Targets in Acute Myeloid Leukemia (AML). Curr Oncol Rep. 2024 04; 26(4):409-420.

View in: PubMed
Badar T, Nanaa A, Atallah E, Shallis RM, Guilherme SCC, Goldberg AD, Saliba AN, Patel A, Bewersdorf JP, DuVall AS, Bradshaw D, Abaza Y, Murthy GSG, Palmisiano N, Zeidan AM, Kota V, Litzow MR. Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood Cancer J. 2024 Feb 20; 14(1):32.

View in: PubMed
Meyer SE. Context is key for FLT3-ITD. Blood. 2023 Mar 23; 141(12):1373-1374.

View in: PubMed
Bi X, Hsu J, Gergis M, Yang Y, Yi D, Gergis U. Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia. Hematol Oncol Stem Cell Ther. 2022 Dec 15; 15(3):131-136.

View in: PubMed
Gamlen HA, Romer-Seibert JS, Lawler ME, Versace AM, Goetz ML, Feng Y, Guryanova OA, Palmisiano N, Meyer SE. miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML. Clin Cancer Res. 2022 10 14; 28(20):4574-4586.

View in: PubMed
Elgarten CW, Otto WR, Shenton L, Stein MT, Horowitz J, Aftandilian C, Arnold SD, Bona KO, Caywood E, Collier AB, Gramatges MM, Henry M, Lotterman C, Maloney K, Modi AJ, Mian A, Mody R, Morgan E, Raetz EA, Verma A, Winick N, Wilkes JJ, Yu JC, Aplenc R, Fisher BT, Getz KD. Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia. Infect Control Hosp Epidemiol. 2023 02; 44(2):222-229.

View in: PubMed
Bi X, French Z, Palmisiano N, Wen KY, Wilde L. The prognostic impact of cigarette smoking on survival in acute myeloid leukemia with TP53 mutations and/or 17p deletions. Ann Hematol. 2022 Jun; 101(6):1251-1259.

View in: PubMed
Venugopal K, Feng Y, Nowialis P, Xu H, Shabashvili DE, Berntsen CM, Kaur P, Krajcik KI, Taragjini C, Zaroogian Z, Casellas Román HL, Posada LM, Gunaratne C, Li J, Dupéré-Richer D, Bennett RL, Pondugula S, Riva A, Cogle CR, Opavsky R, Law BK, Bhaduri-McIntosh S, Kubicek S, Staber PB, Licht JD, Bird JE, Guryanova OA. DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication Forks. Clin Cancer Res. 2022 Feb 15; 28(4):756-769.

View in: PubMed
Barwe SP, Sebastian A, Sidhu I, Kolb EA, Gopalakrishnapillai A. Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of GATA1 and STAG2 Mutations in Induced Pluripotent Stem Cells with Trisomy 21. Cells. 2022 02 11; 11(4).

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement